E-SHAP for refractory and relapsing lymphoma: influence of patient selection on response rate.
Aparicio Urtasun
J
J
Gómez Codina
J
J
Molins Palau
C
C
Pastor Borgoñón
M
M
Maestu Maiques
I
I
Munárriz Gandia
B
B
Montalar Salcedo
J
J
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D011379:Prognosis; D015996:Survival Rate